Literature DB >> 15078264

Detailed clinical and ultrasound examination of children and adolescents in a Schistosoma mansoni endemic area in Kenya: hepatosplenic disease in the absence of portal fibrosis.

Birgitte J Vennervald1, LeeCarol Kenty, Anthony E Butterworth, Curtis H Kariuki, Hilda Kadzo, Edmund Ireri, Clifford Amaganga, Gachuhi Kimani, Joseph Mwatha, Amos Otedo, Mark Booth, John H Ouma, David W Dunne.   

Abstract

Hepatosplenic schistosomiasis involving organomegaly, portal fibrosis and portal hypertension has been observed in autopsy studies. Here, we have tested the hypothesis that hepatosplenic disease including organomegaly and markers of increased portal pressure can occur in school aged children in the absence of fibrosis. A case-only study of 96 children aged 7-20 years defined by ultrasound detectable hepatomegaly was undertaken in Makueni district, Kenya. A novel method of clinical examination that involved a consensus scoring by three or four examiners was used to classify children as presenting with severe or moderate hepatosplenic disease after palpation of livers and spleens. Ultrasound examination of livers and spleens was based on the Niamey protocol. Clinical measurements included spleen enlargement along the mid-clavicular and mid-axillary lines, liver enlargement along the mid-sternal (MSL) and mid-clavicular lines, as well as organ consistency. The clinical examination indicated that 9% and 60% of the children had severe or moderate hepatosplenomegaly, respectively. Amongst egg-positive children, all clinical measurements, except MSL liver enlargement, correlated with egg count, as did portal vein diameter, spleen length and liver length measured by ultrasound. Peri-portal fibrosis was not observed in any child, whereas 28% of the children were classified as having increased portal pressure according to World Health Organization criteria. There was no effect of malaria parasitaemia or hepatitis seropositvity on any of the observed parameters. These results indicate that hepatosplenic disease in school-aged children attributable to S. mansoni infection, involving hepatosplenomegaly and increased portal vein diameter, can occur in the absence of peri-portal fibrosis.

Entities:  

Mesh:

Year:  2004        PMID: 15078264     DOI: 10.1111/j.1365-3156.2004.01215.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  32 in total

Review 1.  The WHO ultrasonography protocol for assessing hepatic morbidity due to Schistosoma mansoni. Acceptance and evolution over 12 years.

Authors:  Tarik el Scheich; Martha C Holtfreter; Hendrik Ekamp; Daman D Singh; Rodrigo Mota; Christoph Hatz; Joachim Richter
Journal:  Parasitol Res       Date:  2014-09-27       Impact factor: 2.289

2.  Hepatosplenomegaly is associated with low regulatory and Th2 responses to schistosome antigens in childhood schistosomiasis and malaria coinfection.

Authors:  Shona Wilson; Frances M Jones; Joseph K Mwatha; Gachuhi Kimani; Mark Booth; H Curtis Kariuki; Birgitte J Vennervald; John H Ouma; Eric Muchiri; David W Dunne
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

3.  Schistosoma mansoni morbidity among school-aged children: a SCORE project in Kenya.

Authors:  Aaron M Samuels; Elizabeth Matey; Pauline N M Mwinzi; Ryan E Wiegand; Geoffrey Muchiri; Edmund Ireri; Molly Hyde; Susan P Montgomery; Diana M S Karanja; W Evan Secor
Journal:  Am J Trop Med Hyg       Date:  2012-09-17       Impact factor: 2.345

4.  High Schistosoma mansoni disease burden in a rural district of western Zambia.

Authors:  Mable M Mutengo; James C L Mwansa; Takafira Mduluza; Sandie Sianongo; James Chipeta
Journal:  Am J Trop Med Hyg       Date:  2014-09-22       Impact factor: 2.345

5.  Sinus surgery combined with antifungal therapy is effective in the treatment of invasive Aspergillus sinusitis in neutropenic patients with cancer.

Authors:  R Y Hachem; M R Boktour; H A Hanna; R Husni; E Y Hanna; X Keutgen; B Shukrallah; I I Raad
Journal:  Infection       Date:  2008-08-25       Impact factor: 3.553

Review 6.  Review: analysis of parasite and other skewed counts.

Authors:  Neal Alexander
Journal:  Trop Med Int Health       Date:  2012-06       Impact factor: 2.622

7.  Identification of a novel antigen of Schistosoma mansoni shared with Plasmodium falciparum and evaluation of different cross-reactive antibody subclasses induced by human schistosomiasis and malaria.

Authors:  Christine Pierrot; Shona Wilson; Hélène Lallet; Sophia Lafitte; Frances M Jones; Wassim Daher; Monique Capron; David W Dunne; Jamal Khalife
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

8.  Health implications of chronic hepatosplenomegaly in Kenyan school-aged children chronically exposed to malarial infections and Schistosoma mansoni.

Authors:  Shona Wilson; Birgitte J Vennervald; Hilda Kadzo; Edmund Ireri; Clifford Amaganga; Mark Booth; H Curtis Kariuki; Joseph K Mwatha; Gachuhi Kimani; John H Ouma; Eric Muchiri; David W Dunne
Journal:  Trans R Soc Trop Med Hyg       Date:  2009-10-08       Impact factor: 2.184

9.  Hepatosplenomegaly associated with chronic malaria exposure: evidence for a pro-inflammatory mechanism exacerbated by schistosomiasis.

Authors:  S Wilson; F M Jones; J K Mwatha; G Kimani; M Booth; H C Kariuki; B J Vennervald; J H Ouma; E Muchiri; D W Dunne
Journal:  Parasite Immunol       Date:  2009-02       Impact factor: 2.280

Review 10.  Epidemiology and control of human schistosomiasis in Tanzania.

Authors:  Humphrey D Mazigo; Fred Nuwaha; Safari M Kinung'hi; Domenica Morona; Angela Pinot de Moira; Shona Wilson; Jorg Heukelbach; David W Dunne
Journal:  Parasit Vectors       Date:  2012-11-28       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.